search
Back to results

Prevention of Diabetes in Overweight/Obese Preadolescent Children (PREDIKID)

Primary Purpose

Overweight Children With Type 2 Diabetes Risk

Status
Completed
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
lifestyle and psycho-educational program
Exercise plus lifestyle and psycho-educational program
Sponsored by
University of the Basque Country (UPV/EHU)
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Overweight Children With Type 2 Diabetes Risk

Eligibility Criteria

8 Years - 12 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Overweight/obese children aged between 8 and 12 years, meeting the international criteria for classification for T2D risk and having at least one parent or caregiver willing to participate in the program sessions will be included

Exclusion Criteria:

  • Children with any medical condition that could affect the results of the study or that limits physical activity will be excluded

Sites / Locations

  • Pediatric Endocrinology Unit of the University Hospital of Araba (HUA)

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Control group

Exercise group

Arm Description

Family-based lifestyle education and psycho-educational program

Supervised exercise plus family-based lifestyle education and psycho-educational program

Outcomes

Primary Outcome Measures

Insulin resistance
The Homeostasis model assessment index will be calculated as fasting insulin concentration (microU/mL) x fasting glucose concentration (mmol/L)/22.5.
microRNA expression in circulating exosomes and in blood peripheral mononuclear cells
The expression of miRNAs will be measured in circulating exosomes and in white blood cells (MiSeq-Ilumina)

Secondary Outcome Measures

Ectopic fat: pancreatic and liver fat accumulation
Hepatic and pancreatic fat will be measured by magnetic resonance
Total, abdominal and visceral adiposity
Total and abdominal adiposity will be measured by dual energy X-ray absorptiometry. Visceral adiposity will be measured by magnetic resonance imaging
Anthropometry and blood pressure
Body mass, height and waist circumference will be measured following standard protocols at least twice until consistent measures will be obtained and thereafter, body mass index (BMI) and waist to height ratio will be calculated. Systolic and diastolic blood pressure measurements will be performed following the recommendations for children using an arm blood pressure oscillometric monitor device
Cardiorespiratory fitness
Cardiorespiratory fitness will be assessed by two different tests: (i) The 20m shuttle run test in which the equation reported by Léger et al. will be used to estimate the maximum oxygen consumption (VO2max, ml/kg/min) from the 20m shuttle run test scores, and (ii) Direct cardiopulmonary exercise progressive incremental treadmill test using the modified American College of Sports Medicine protocol with respiratory gas analysis to exhaustion
Carotid intima-media thickness
carotid intima-media thickness will be measured by ultrasound according to international recommendations.
Inflammation and biochemical cardiovascular disease risk factors
Fasting lipid profile (total-, HDL- and LDL-cholesterol, and triglycerides), glucose, insulin, and hemoglobin A1c, cytokines (e.g. tumor necrosis factor alpha and IL-6) adipokines (e.g leptin and adiponectin), hepatokines (fetuin-A and fibroblast growth factor-21), liver enzymes (alanine aminotransferase, aspartate aminotransferase and gamma-glutamyl transferase), C-reactive protein, thyroid hormones (thyroid stimulating hormone, triiodothyronine and free thyroxine), urea, bilirubin and uric acid

Full Information

First Posted
January 16, 2017
Last Updated
November 19, 2020
Sponsor
University of the Basque Country (UPV/EHU)
Collaborators
Ministerio de Economía y Competitividad, Spain, Universidad Pública de Navarra
search

1. Study Identification

Unique Protocol Identification Number
NCT03027726
Brief Title
Prevention of Diabetes in Overweight/Obese Preadolescent Children
Acronym
PREDIKID
Official Title
Prevention of Diabetes in Overweight/Obese Preadolescent Children Through a Family-based Intervention Program Including Supervised Exercise; the PREDIKID Study
Study Type
Interventional

2. Study Status

Record Verification Date
November 2020
Overall Recruitment Status
Completed
Study Start Date
March 7, 2017 (Actual)
Primary Completion Date
September 15, 2018 (Actual)
Study Completion Date
September 15, 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of the Basque Country (UPV/EHU)
Collaborators
Ministerio de Economía y Competitividad, Spain, Universidad Pública de Navarra

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Background: The global pandemic obesity has led to increased risk for prediabetes and type 2 diabetes (T2D). Objectives: (i) To evaluate the effect of a 22 weeks multidisciplinary intervention program including exercise on T2D risk in pre-adolescents with high risk to develop T2D, and (ii) To identify the profile of microRNA in circulating exosomes and in blood peripheral mononuclear cells in pre-adolescents with high risk to develop T2D and its response to a multidisciplinary intervention program including exercise.
Detailed Description
Background: The global pandemic obesity has led to increased risk for prediabetes and type 2 diabetes (T2D). Objectives: (i) To evaluate the effect of a 22 weeks multidisciplinary intervention program including exercise on T2D risk in pre-adolescents with high risk to develop T2D, and (ii) To identify the profile of microRNA in circulating exosomes and in blood peripheral mononuclear cells in pre-adolescents with high risk to develop T2D and its response to a multidisciplinary intervention program including exercise. Design, participants and methods: A total of 84 children with high risk of type 2 diabetes mellitus aged 8-12 years will be included and randomly assigned to control (N=42) or intervention (N=42) groups. The control group will receive a family-based lifestyle education and psycho-educational program (2 days/month), while the intervention group will attend the same lifestyle education and psycho-educational program plus the exercise program (3 days/week). The duration of training sessions will be 90 min of exercise, including warm-up, moderate to vigorous aerobic activities, and strength exercises. The following measurements will be evaluated at baseline prior to randomization and after the intervention: fasting, insulin glucose, and hemoglobin A1c; total and abdominal fat (dual X-ray absorptiometry); pancreatic, hepatic and visceral fat (magnetic resonance imaging); systolic and diastolic blood pressure; fasting leptin, adiponectin, fibroblast growth factor-21, fetuin-A, hs-C-reactive protein, tumor necrosis factor-alfa, interleukin (IL)-1beta and IL-6 and lipid profile; carotid intima-media thickness (ultrasonography), microRNA expression in circulating exosomes and in blood peripheral mononuclear cells (MiSeq-Illumina); functional peak aerobic capacity (cardiopulmonary exercise testing and 20m shuttle run test). Changes in dietary habits (food frequency questionnaire and two non-consecutive 24h recalls), physical activity and sleep (accelerometry); sex, age, socioeconomic status and pubertal status will be used as potential confounders. Discussion/Conclusions: Early prevention and identification of children with high risk to develop T2D could help to reduce the morbidity and mortality associated with the disease.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Overweight Children With Type 2 Diabetes Risk

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
84 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Control group
Arm Type
Active Comparator
Arm Description
Family-based lifestyle education and psycho-educational program
Arm Title
Exercise group
Arm Type
Experimental
Arm Description
Supervised exercise plus family-based lifestyle education and psycho-educational program
Intervention Type
Behavioral
Intervention Name(s)
lifestyle and psycho-educational program
Intervention Description
The family-based healthy lifestyle education and psychological education program will be followed once every two weeks (11 sessions over 22 weeks) for 90 minutes (45 minutes in the healthy lifestyle education program and 45 minutes in the psycho-educational intervention). The sessions of the healthy lifestyle education and psycho-educational interventions will be developed simultaneously and delivered to both parents (or caregivers) and children, separately. The family-based healthy lifestyle education program will be conducted by experienced nutritionists and the psycho-educational program by experienced psychologists in behavior changes
Intervention Type
Other
Intervention Name(s)
Exercise plus lifestyle and psycho-educational program
Intervention Description
The intervention group will attend the same lifestyle education and psycho-educational program plus the exercise program. The exercise group will do exercise 3 days/week, 90 minutes per session, over a 22-week period. The program will be offered to the families five days per week to choose a total of three days/week. Sessions will be designed and supervised by exercise specialists. The duration of training sessions will be 90 minutes of exercise, including warm-up, moderate to vigorous aerobic activities, and strength exercises
Primary Outcome Measure Information:
Title
Insulin resistance
Description
The Homeostasis model assessment index will be calculated as fasting insulin concentration (microU/mL) x fasting glucose concentration (mmol/L)/22.5.
Time Frame
Baseline and at the end of the 22 weeks of intervention
Title
microRNA expression in circulating exosomes and in blood peripheral mononuclear cells
Description
The expression of miRNAs will be measured in circulating exosomes and in white blood cells (MiSeq-Ilumina)
Time Frame
Baseline and at the end of the 22 weeks of intervention
Secondary Outcome Measure Information:
Title
Ectopic fat: pancreatic and liver fat accumulation
Description
Hepatic and pancreatic fat will be measured by magnetic resonance
Time Frame
Baseline and at the end of the 22 weeks of intervention
Title
Total, abdominal and visceral adiposity
Description
Total and abdominal adiposity will be measured by dual energy X-ray absorptiometry. Visceral adiposity will be measured by magnetic resonance imaging
Time Frame
Baseline and at the end of the 22 weeks of intervention
Title
Anthropometry and blood pressure
Description
Body mass, height and waist circumference will be measured following standard protocols at least twice until consistent measures will be obtained and thereafter, body mass index (BMI) and waist to height ratio will be calculated. Systolic and diastolic blood pressure measurements will be performed following the recommendations for children using an arm blood pressure oscillometric monitor device
Time Frame
Baseline and at the end of the 22 weeks of intervention
Title
Cardiorespiratory fitness
Description
Cardiorespiratory fitness will be assessed by two different tests: (i) The 20m shuttle run test in which the equation reported by Léger et al. will be used to estimate the maximum oxygen consumption (VO2max, ml/kg/min) from the 20m shuttle run test scores, and (ii) Direct cardiopulmonary exercise progressive incremental treadmill test using the modified American College of Sports Medicine protocol with respiratory gas analysis to exhaustion
Time Frame
Baseline and at the end of the 22 weeks of intervention
Title
Carotid intima-media thickness
Description
carotid intima-media thickness will be measured by ultrasound according to international recommendations.
Time Frame
Baseline and at the end of the 22 weeks of intervention
Title
Inflammation and biochemical cardiovascular disease risk factors
Description
Fasting lipid profile (total-, HDL- and LDL-cholesterol, and triglycerides), glucose, insulin, and hemoglobin A1c, cytokines (e.g. tumor necrosis factor alpha and IL-6) adipokines (e.g leptin and adiponectin), hepatokines (fetuin-A and fibroblast growth factor-21), liver enzymes (alanine aminotransferase, aspartate aminotransferase and gamma-glutamyl transferase), C-reactive protein, thyroid hormones (thyroid stimulating hormone, triiodothyronine and free thyroxine), urea, bilirubin and uric acid
Time Frame
Baseline and at the end of the 22 weeks of intervention
Other Pre-specified Outcome Measures:
Title
Confounding variable: puberty stage
Description
The pediatrician will evaluate Tanner staging by direct examination with breast palpation in girls and testicular measurement by orchidometer in boys.
Time Frame
Baseline
Title
Confounding variable:physical activity and sleep
Description
Children will wear an activity monitor on the wrist for 7 consecutive days for 24 hours to record physical activity intensity levels and patterns, as well as sleeping habits and participants will also complete a diary log
Time Frame
Baseline and at the end of the 22 weeks of intervention
Title
Confounding variable: dietary habits
Description
Dietary intake will be evaluated by two non-consecutive 24h recalls within a period of seven days by nutritionists and a validated food frequency questionnaire
Time Frame
Baseline and at the end of the 22 weeks of intervention
Title
Confounding variable: sedentary behaviors
Description
Sedentary behaviors such as watching television, playing computer games, playing video games or phone games, and surfing the Internet will be self-reported by the children using validated questionnaires
Time Frame
Baseline and at the end of the 22 weeks of intervention
Title
Confounding variable: Socio-demographic variables:
Description
Information about socioeconomic status, demographic characteristics and family medical history of obesity, diabetes, dyslipidemia and hypertension will be collected. Socioeconomic status will be evaluated using The Family Affluence Scale (74) and parental education level and parental occupation. As demographic characteristics date of birth, sex, ethnicity and family structure will be recorded.
Time Frame
Baseline

10. Eligibility

Sex
All
Minimum Age & Unit of Time
8 Years
Maximum Age & Unit of Time
12 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Overweight/obese children aged between 8 and 12 years, meeting the international criteria for classification for T2D risk and having at least one parent or caregiver willing to participate in the program sessions will be included Exclusion Criteria: Children with any medical condition that could affect the results of the study or that limits physical activity will be excluded
Facility Information:
Facility Name
Pediatric Endocrinology Unit of the University Hospital of Araba (HUA)
City
Vitoria-Gasteiz
State/Province
Araba
ZIP/Postal Code
01009
Country
Spain

12. IPD Sharing Statement

Citations:
PubMed Identifier
26408054
Citation
Medrano M, Maiz E, Maldonado-Martin S, Arenaza L, Rodriguez-Vigil B, Ortega FB, Ruiz JR, Larrarte E, Diez-Lopez I, Sarasua-Miranda A, Tobalina I, Barrenechea L, Perez-Asenjo J, Kannengiesser S, Manhaes-Savio A, Echaniz O, Labayen I. The effect of a multidisciplinary intervention program on hepatic adiposity in overweight-obese children: protocol of the EFIGRO study. Contemp Clin Trials. 2015 Nov;45(Pt B):346-355. doi: 10.1016/j.cct.2015.09.017. Epub 2015 Sep 25.
Results Reference
background
PubMed Identifier
28793919
Citation
Arenaza L, Medrano M, Amasene M, Rodriguez-Vigil B, Diez I, Grana M, Tobalina I, Maiz E, Arteche E, Larrarte E, Huybrechts I, Davis CL, Ruiz JR, Ortega FB, Margareto J, Labayen I. Prevention of diabetes in overweight/obese children through a family based intervention program including supervised exercise (PREDIKID project): study protocol for a randomized controlled trial. Trials. 2017 Aug 10;18(1):372. doi: 10.1186/s13063-017-2117-y.
Results Reference
derived

Learn more about this trial

Prevention of Diabetes in Overweight/Obese Preadolescent Children

We'll reach out to this number within 24 hrs